ISIS PHARMACEUTICALS INC 4
4 · ISIS PHARMACEUTICALS INC · Filed Jul 6, 2005
Insider Transaction Report
Form 4
Wedel Mark K
VP & Chief Medical Officer
Transactions
- Other
Common Stock
2005-07-01$3.36/sh+856$2,874→ 8,060 total
Footnotes (1)
- [F1]Reporting 856 shares acquired under the Isis Pharmaceuticals, Inc. 2000 Employee Stock Purchase Plan on July 1, 2005.